THERAPEUTIC AGENT COMPRISING GLYCOLIPID DERIVATIVE CAPABLE OF INHIBITING THE FUNCTION OF NKT CELL AS ACTIVE INGREDIENT
申请人:Japan as represented by President of National
Center of Neurology and Psychiatry
公开号:EP1952814A1
公开(公告)日:2008-08-06
A therapeutic drug for diseases, in which NKT cells or stimulus of NKT cells is involved in deterioration of disease conditions, containing, as an active ingredient, a glycolipid derivative having the formula (I):
wherein R1 indicates an aldopyranose residue, R2 indicates a hydrogen atom or a hydroxy group, A indicates -CH2-, -CH(OH)-CH2- or -CH=CHCH2-, x indicates an integer of 13 to 16 and y indicates an integer of 0 to 25
or its pharmacologically acceptable hydrate or solvate.
一种治疗疾病的药物,其中NKT细胞或NKT细胞的刺激参与了疾病状况的恶化,包含一种具有以下式(I)的糖脂衍生物作为活性成分:其中R1表示醛基吡喃糖残基,R2表示氢原子或羟基,A表示-CH2-,-CH(OH)-CH2-或-CH=CHCH2-,x表示13至16的整数,y表示0至25的整数,或其药理学上可接受的水合物或溶剂化合物。